Peter Geschek
Contributor since: 2012
Latest Articles
Pfizer Vs. Eli Lilly, Novartis In Breast Cancer Race
Sovaldi's Patent War
Biogen's Winning Strategy
Sovaldi's Terrific Launch
Johnson & Johnson's Success In Cardiac Ablation
Pfizer's Coming Superdrug
GLP-1 Race In Diabetes: Eli Lilly Vs. Competitors
The Vaccine Prevnar 13 And Its Competitor: Pfizer Vs. Merck
Attack On Lung Cancer: Eli Lilly Vs. Rivals
Innovation In Huntington's Disease: Auspex Vs. Rivals
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
The Hep C Race Is Heating Up: AbbVie Vs. Gilead
The Dream Of The Insulin Pill: Oramed Vs. Rivals
The Leukemia Race: Gilead Vs. Johnson & Johnson, Roche
The CoreValve Battle: Medtronic Vs. Edwards Lifesciences
Liver Drug Race: Intercept Pharma Vs. Rivals
High Stakes Intrigue In Hep C: Bristol-Myers Vs. Gilead
The Psoriatic Arthritis Race: Celgene Vs. Johnson & Johnson
Capricor: Can A Scarred Heart Be Repaired?
Amgen Vs. Merck, Lilly In Osteoporosis Competition
Is Puma Biotech's High Stock Price Justified?
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
Acadia: The Best Hope For Parkinson's Psychosis Sufferers
Biogen's Biosimilars Vs. Amgen, Johnson & Johnson
Merck Vs. Bristol In PD-1 Cancer Drug Race
Hep C Price War? Abbvie Vs. Gilead
Oncomed, Celgene Vs Rivals In Cancer Stem Cells Race
HeartWare Vs. Thoratec In The Heart Pump Race
Johnson & Johnson Vs. Pfizer, Bristol In The Race Of Anticoagulants
Celgene Vs. Amgen In Multiple Myeloma Battle
Portola's Antidote Could Benefit Pfizer, Bristol-Myers, J&J